Neogen Corporation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Neogen Corporation (NEOG) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $3.92 million for the 12-month period ending 2017-05-31, per its 10-K filed 2019-07-30.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2019-07-30
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2017-05-31 was $251.00K.
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2017-02-28 was $1.20M.
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-11-30 was -$725.52M.
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-08-31 was $728.00M.
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2017 was $3.92M, a 33.17% increase from fiscal 2016.
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $2.94M, a 18.99% increase from fiscal 2015.
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $2.48M, a 47.97% decline from fiscal 2014.
- Neogen Corporation adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $4.76M, a 52.81% increase from fiscal 2013.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|---|
| 2017-05-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | $1.45M derived: sum of 2 quarters · filed 2019-07-30 | -$724.08M derived: sum of 3 quarters · filed 2019-07-30 | $3.92M 10-K · filed 2019-07-30 |
| 2017-02-28 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | -$724.33M derived: sum of 2 quarters · filed 2017-03-31 | $3.67M 10-Q · filed 2017-03-31 | |
| 2016-11-30 | -$725.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | $2.48M 10-Q · filed 2016-12-29 | ||
| 2016-08-31 | $728.00M 10-Q · filed 2016-09-30 | |||
| 2016-05-31 | $2.94M 10-K · filed 2018-07-27 | |||
| 2015-05-31 | $2.48M 10-K · filed 2017-07-28 | |||
| 2014-05-31 | $4.76M 10-K · filed 2016-07-29 | |||
| 2013-11-30 | $522.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $2.11M 10-Q · filed 2014-01-09 | $3.35M derived: sum of 3 quarters · filed 2015-07-30 | $3.72M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-08-31 | $1.58M 10-Q · filed 2013-09-30 | $2.83M derived: sum of 2 quarters · filed 2015-07-30 | $3.20M derived: sum of 3 quarters · filed 2015-07-30 | $3.67M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $1.61M derived: sum of 2 quarters · filed 2015-07-30 | $2.08M derived: sum of 3 quarters · filed 2015-07-30 | $3.11M 10-K · filed 2015-07-30 |
| 2013-02-28 | $368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $839.00K derived: sum of 2 quarters · filed 2013-03-28 | $1.87M 10-Q · filed 2013-03-28 | |
| 2012-11-30 | $471.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $1.50M 10-Q · filed 2012-12-28 | ||
| 2012-08-31 | $1.03M 10-Q · filed 2012-09-28 | |||
| 2012-05-31 | $1.83M 10-K · filed 2014-07-30 | |||
| 2011-05-31 | $2.99M 10-K · filed 2013-07-30 | |||
| 2010-05-31 | $709.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |